Teodoro, J. S., Da Silva, R. T., Machado, I. F., Panisello-Roselló, A., Roselló-Catafau, J., Rolo, A. P., & Palmeira, C. M. (2022). Shaping of hepatic ischemia/reperfusion events: the crucial role of mitochondria. Cells, 11, 688.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakata, Y., Kono, H., Akazawa, Y., Hirayama, K., Wakana, H., Fukushima, H., Sun, C., & Fujii, H. (2022). Role of podoplanin and Kupffer cells in liver injury after ischemia–reperfusion in mice. Surgery Today, 52, 1–10.

Article  Google Scholar 

Zhong, C., Yang, J., Zhang, Y., Fan, X., Fan, Y., Hua, N., Li, D., Jin, S., Li, Y., Chen, P., Chen, Y., Cai, X., Zhang, Y., Jiang, L., Yang, W., Yu, P., & Lin, H. (2023). TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression. Research, 6, 0159.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reue, K., & Wang, H. (2019). Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: metabolic and inflammatory disorders. Journal of Lipid Research, 60, 728–733.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim, J., Lee, Y.-J., Kim, J. M., Lee, S. Y., Bae, M.-A., Ahn, J. H., Han, D. C., & Kwon, B. M. (2016). PPARγ agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARγ phosphatase. The International Journal of Biochemistry and Cell Biology, 81, 57–66.

Article  CAS  PubMed  Google Scholar 

Jia, M., Zhang, H., Qin, Q., Hou, Y., Zhang, X., Chen, D., Zhang, H., & Chen, Y. (2021). Ferroptosis as a new therapeutic opportunity for nonviral liver disease. European Journal of Pharmacology, 908, 174319.

Article  CAS  PubMed  Google Scholar 

Meana, C., Peña, L., Lordén, G., Esquinas, E., Guijas, C., Valdearcos, M., Balsinde, J., & Balboa, M. A. (2014). Lipin-1 integrates lipid synthesis with proinflammatory responses during TLR activation in macrophages. The Journal of Immunology, 193, 4614–4622.

Article  CAS  PubMed  Google Scholar 

Zhang, X., Huang, S., Zhuang, Z., Han, X., Xie, M., Yu, S., Hua, M., Liang, Z., Meng, C., Yin, L., Zhuang, X., & Chen, S. (2023). Lipin2 ameliorates diabetic encephalopathy via suppressing JNK/ERK-mediated NLRP3 inflammasome overactivation. International Immunopharmacology, 118, 109930.

Article  CAS  PubMed  Google Scholar 

Akbari-Kordkheyli, V., Azizi, S., & Khonakdar-Tarsi, A. (2019). Effects of silibinin on hepatic warm ischemia-reperfusion injury in the rat model. Iranian Journal of Basic Medical Sciences, 22, 789–796.

PubMed  PubMed Central  Google Scholar 

Haddad, Y., Vallerand, D., Brault, A., & Haddad, P. S. (2011). Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evidence-Based Complementary and Alternative Medicine, 2011, nep164.

Article  PubMed  PubMed Central  Google Scholar 

Sangeetha, N., Aranganathan, S., & Nalini, N. (2010). Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer. Investigational New Drugs, 28, 225–233.

Article  CAS  PubMed  Google Scholar 

Muthumani, M., & Prabu, S. M. (2014). Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. Cardiovascular Toxicology, 14, 83–97.

Article  CAS  PubMed  Google Scholar 

Zarpou, S., Mosavi, H., Bagheri, A., Shafaroudi, M. M., & Khonakdar-Tarsi, A. (2021). NF-κB and NLRP3 gene expression changes during warm hepatic ischemia-reperfusion in rats with and without silibinin. Gastroenterology and Hepatology From Bed to Bench, 14, 267–275.

PubMed  PubMed Central  Google Scholar 

Kauntz, H. (2012). Cellular and molecular targets of silibinin, a natural flavonoid, in colorectal cancer prevention and therapy: Université de Strasbourg.

Habibi Ghahfarrokhi, S., Heidari-Soureshjani, S., Sherwin, C. M., & Azadegan-Dehkordi, Z. (2024). Efficacy and mechanisms of silybum marianum, silymarin, and silibinin on rheumatoid arthritis and osteoarthritis symptoms: a systematic review. Current Rheumatology Reviews, 20, 414–425.

Article  Google Scholar 

Giménez-Bastida, J. A., Gonzalez-Sarrias, A., Laparra-Llopis, J. M., Schneider, C., & Espín, J. C. (2021). Targeting mammalian 5-lipoxygenase by dietary phenolics as an anti-inflammatory mechanism: a systematic review. International Journal of Molecular Sciences, 22, 7937.

Article  PubMed  PubMed Central  Google Scholar 

Wu, J., Wen, L., Liu, X., Li, Q., Sun, Z., Liang, C., Xie, F., & Li, X. (2024). Silybin: a review of its targeted and novel agents for treating liver diseases based on pathogenesis. Phytotherapy Research, 38, 5713–5740.

Article  CAS  PubMed  Google Scholar 

Aamani, N., Bagheri, A., Qajari, N. M., Shafaroudi, M. M., & Khonakdar-Tarsi, A. (2022). JNK and p38 gene and protein expression during liver ischemia-reperfusion in a rat model treated with silibinin. Iranian Journal of Basic Medical Sciences, 25, 1373–1381.

PubMed  PubMed Central  Google Scholar 

Akbari Kordkheyli, V., Azizi, S., & Khonakdar-Tarsi, A. (2018). Effects of silibinin on nitric oxide synthase genes expression during hepatic warm ischemia-reperfusion in adult male rats. Journal of Mazandaran University of Medical Sciences, 28, 1–12.

Google Scholar 

Musavi, H., Safaee, M. S., Nasiri, Z., Ghorbani, F., Mohamadi, P., & Rostami, E., et al. (2024). Evaluating the effect of silibinin on the expression of pannexin1 gene during hepatic ischemia-reperfusion. Crescent Journal of Medical and Biological Sciences, 11, 190–194.

Article  Google Scholar 

Qajari, N. M., Shafaroudi, M. M., Gholami, M., & Khonakdar-Tarsi, A. (2020). Silibinin treatment results in reducing OPA1&MFN1 genes expression in a rat model hepatic ischemia–reperfusion. Molecular Biology Reports, 47, 3271–3280.

Article  CAS  PubMed  Google Scholar 

Fan, C., Zwacka, R. M., & Engelhardt, J. F. (1999). Therapeutic approaches for ischemia/reperfusion injury in the liver. Journal of Molecular Medicine, 77, 577–592.

Article  CAS  PubMed  Google Scholar 

Panisello-Roselló, A., Lopez, A., Folch-Puy, E., Carbonell, T., Rolo, A., Palmeira, C., Adam, R., Net, M., & Roselló-Catafau, J. (2018). Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update. World journal of Gastroenterology, 24, 2984–2994.

Article  PubMed  PubMed Central  Google Scholar 

Teoh, N. C., & Farrell, G. C. (2003). Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. Journal of Gastroenterology and Hepatology, 18, 891–902.

Article  CAS  PubMed  Google Scholar 

Qavami, N., Naghdi, B. H., Labbafi, M., & Mehrafarin, A. (2013). A review on pharmacological, cultivation and biotechnology aspects of milk thistle (Silybum marianum (L.) Gaertn.).

Zarrelli, A., Romanucci, V., Tuccillo, C., Federico, A., Loguercio, C., Gravante, R., & Di Fabio, G. (2014). New silibinin glyco-conjugates: Synthesis and evaluation of antioxidant properties. Bioorganic & Medicinal Chemistry Letters, 24, 5147–5149.

Article  CAS  Google Scholar 

Jaeschke, H. (2000). Reactive oxygen and mechanisms of inflammatory liver injury. Journal of Gastroenterology and Hepatology, 15, 718–724.

Article  CAS  PubMed  Google Scholar 

Yildiz, F., Coban, S., Terzi, A., Ates, M., Aksoy, N., Cakir, H., Ocak, A. R., & Bitiren, M. (2008). Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World Journal of Gastroenterology, 14, 5204–5209.

Article  PubMed  PubMed Central  Google Scholar 

Wu, J.-W., Lin, L.-C., Hung, S.-C., Chi, C.-W., & Tsai, T.-H. (2007). Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. Journal of Pharmaceutical and Biomedical Analysis, 45, 635–641.

Article  CAS  PubMed  Google Scholar 

Akbari-Kordkheyli, V., Abbaszadeh-Goudarzi, K., Nejati-Laskokalayeh, M., Zarpou, S., & Khonakdar-Tarsi, A. (2019). The protective effects of silymarin on ischemia-reperfusion injuries: A mechanistic review. Iranian Journal of Basic Medical Sciences, 22, 968–976.

PubMed  PubMed Central  Google Scholar 

Zhou, Z., Ye, T. J., Bonavita, G., Daniels, M., Kainrad, N., Jogasuria, A., & You, M. (2019). Adipose‐specific lipin‐1 overexpression renders hepatic ferroptosis and exacerbates alcoholic steatohepatitis in mice. Hepatology Communications, 3, 656–669.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin, H., Hu, M., Liang, X., Ajmo, J. M., Li, X., Bataller, R., Odena, G., Stevens, Jr, S. M., & You, M. (2014). Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology, 146, 801–811.

Article  CAS  PubMed